Tech Company Financing Transactions

RaNA Therapeutics Funding Round

RaNA Therapeutics secured a $12 million funding round on 12/31/2012. Investors included Atlas Venture and private investors.

Transaction Overview

Company Name
Announced On
12/31/2012
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Undisclosed
Investors

Atlas Venture (Jean-François Formela)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
200 Sidney St. 310
Cambridge, MA 02139
USA
Email Address
Overview
RaNA Therapeutics is a biotechnology company using its proprietary RNA upregulation platform to discover and develop highly selective epigenetic modulators of gene expression. RaNA's technology upregulates the expression of desirable genes that can prevent or treat disease.
Profile
RaNA Therapeutics LinkedIn Company Profile
Social Media
RaNA Therapeutics Company Twitter Account
Company News
RaNA Therapeutics News
Facebook
RaNA Therapeutics on Facebook
YouTube
RaNA Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Ronald Renaud
  Ronald Renaud LinkedIn Profile  Ronald Renaud Twitter Account  Ronald Renaud News  Ronald Renaud on Facebook
VP - Bus. Development
Brian Fenton
  Brian Fenton LinkedIn Profile  Brian Fenton Twitter Account  Brian Fenton News  Brian Fenton on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/31/2012: FreeWheel venture capital transaction
Next: 12/31/2012: SmarterHQ venture capital transaction

 

Share this article

 


News on VC Transactions

We do our best to report on every notable VC transaction. VC transactions on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary